¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ : 2024-03-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ : 2024-03-23
±³À°ÀÏÀÚ : 2024-03-23
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : ´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸

´ã´çÀÚ : ¼ÛÁÖ¿µ
¿¬¶ôó : 02-585-5455

À̸ÞÀÏ : ksns1987@gmail.com

±³À°Á¾·ù : ½Å°æ¿Ü°ú, ÀÇ»çÇÐ, ÀÇÇб³À°

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 20,000¿ø  

ºñ°í ȸ¿ø 1¸¸¿ø, ºñȸ¿ø 2¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:10~09:30 The first choice of osteoporosis and osteopenia: Raloxifene and Vit. D Áø¿ëÁØ (ÀÎÁ¦´ë )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:30~09:50 Lifelong sequential treatment of osteoporosis Á¤Á¦ÈÆ (¼øõÇâ´ë )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:50~10:10 Romosozumab use of clinical practice in spine field ±Ç¿µ¹Î (µ¿¾Æ´ë )

Åä·Ð 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:10~10:20 Discussion ()

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:45~11:05 Treat-to-target strategy of osteoporosis management ÀÌÀ¯¹Ì (¿¬¼¼´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:05~11:25 Guidelines for dental treatment during osteoporis treatment ±Ç¿ë´ë (°æÈñÄ¡´ë ±¸°­¾Ç¾È¸é¿Ü°ú )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:25~11:45 BMP pathway and research for bone regeneration ÃÖÁ¦¿ë(°æºÏÀÇ´ë ¼¼Æ÷»ýÈ­Çб³½Ç )

Åä·Ð 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:45~11:55 Discussion ()

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 13:30~13:45 ÃÊ·Ï: Comparison of the difference between vertebral height restoration and global sagittal alignment after percutaneous vertebroplasty in thoracolumbar junction (unilateral vs. bilateral) ±è±¤·Ä (´ë±¸Ä«Å縯´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 13:45~14:00 ÃÊ·Ï: Radiologic fusion rates of OLIF surgery using E-coli derived BMP-2 ÀÌ»ó¿ì (°æºÏ´ë )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:00~14:15 ÃÊ·Ï: Evaluation of the association between 2nd osteoporotic compression fractures and paraspinal muscle mass volume mesasured on MRI À±Á¦ÈÖ(¾ÆÁÖ´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:15~14:30 ÃÊ·Ï: Does ossification of the longitudinal ligament nifluence the fusion rate of posterior cervical fusion? ÀåÇöÁØ(¿¬¼¼´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:30~14:45 ÃÊ·Ï: Frailty and sarcopenia: Impact on outcomes following elective degenerative lumbar spine surgery À¯µ¿¿ì(¿µ³²´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:45~15:00 ÃÊ·Ï: Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture Àü¼º¹Î(¿µ³²´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:20~15:40 Screw insertional torque measurement is spine surgery: correlation with BMD and Hounsfield unit ±èÁö¿ë(Ä«Å縯´ë ¼ººó¼¾Æ®º´¿ø)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:40~16:00 The combined effects of RhBMP-2 and systemic RANKL inhibitor in patients with bone density loss undergoing PLIF À¯½ÂÁØ (À»Áö´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:00~16:20 Comparison of the efficacy of romosozumab and teriparatide for the management of osteoporotic vertebral compression fracture ¹ÚÁøÈÆ (¿ï»ê´ë ¾Æ»êº´¿ø )

Åä·Ð 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:20~16:30 Discussion ()

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:30~16:50 Effectiveness of bone cement augmented pedicle screw fixation in severe osteoporotic patients ³ë¼ºÇö(¾ÆÁÖ´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:50~17:10 Mini-open corpectomy and reconstruction cases for fragility fracture induced kyphosis À±¼±±Ù(¿ï»ê´ë ¾Æ»êº´¿ø )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 17:10~17:30 Treatment of super-aged spondylitis patient with osteopenia ±èµ¿È¯(°æ»ó´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ : 2024-03-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°¡Á¤ÀÇÇÐȸ ÀüºÏÁöȸÃá°è¿¬¼ö°­Á : 2024-03-23
´ÙÀ½±Û 2024³â Á¦1Â÷ ´ëÇÑÇÙÀÇÇÐȸ Á¤µµ°ü¸® ½ÉÆ÷Áö¾ö : 2024-03-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20467 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31 0 75 2024-04-17
20466 °æ±â ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30 0 39 2024-04-17
20465 ¼­¿ï Á¦20Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ ÇÁ·Î±×·¥ : 2024-05-26 0 45 2024-04-17
20464 °æ±â 2024³â Á¦86Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-26 0 33 2024-04-17
20463 ¼­¿ï 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-26 0 21 2024-04-17
20462 ¼­¿ï ´ëÇÑÃæ°ÝÆÄÄ¡·áÇÐȸ 2024 Ãá°è Çмú´ëȸ : 2024-05-26 0 21 2024-04-17
20461 ¼­¿ï Áø´Ü ü°èÀû¹®Çå°íÂû ¿öÅ©¼¥ : 2024-05-25 0 29 2024-04-17
20460 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦17ȸ ODOT (One Day Course of Obesity Treatment) : 2024-05-25 0 23 2024-04-17
20459 ¼­¿ï 2024³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-05-24 0 14 2024-04-17
20458 ¼­¿ï 2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24 0 26 2024-04-17
20457 ¼­¿ï 2024³â ¿µµîÆ÷±¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-21 0 31 2024-04-17
20456 ¼­¿ï 2024³â ´ëÇÑÀÓ»ó°Ç°­ÁõÁøÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-19 0 30 2024-04-17
20455 ¼­¿ï Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 38 2024-04-17
20454 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-05-18 0 26 2024-04-17
20453 ¼­¿ï 2024³â ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¦14ȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 31 2024-04-17
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷